Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Praziquantel versus antimalarial combinations for treatment of pediatric schistosomiasis in Kirinyaga County
PACTR202001919442161Phase 3Completed
- Sponsor
- Kenya Medical Research Institute
- Start
- Jan 2018
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of praziquantel, artesunate, sulfamethoxypyrazine, pyrimethamine, amodiaquine and 3 more in schistosomiasis (5 arms), sponsored by Kenya Medical Research Institute. Started Jan 2018; status: completed.
02
Drugs
praziquantelartesunatesulfamethoxypyrazinepyrimethamineamodiaquine
03
Conditions
schistosomiasis
Beyond the preview
Go deeper on PACTR202001919442161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202001919442161.